CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $477,000 | -60.7% | 587,011 | +37.3% | 0.02% | -65.5% |
| Q4 2017 | $1,214,000 | -14.3% | 427,578 | -13.6% | 0.06% | -28.6% |
| Q3 2017 | $1,416,000 | +19.4% | 495,018 | +3.1% | 0.08% | -21.4% |
| Q2 2017 | $1,186,000 | +39.2% | 480,018 | +103.4% | 0.10% | +15.3% |
| Q1 2017 | $852,000 | +22.4% | 236,055 | +20.0% | 0.08% | +1.2% |
| Q4 2016 | $696,000 | +12.3% | 196,715 | +28.1% | 0.08% | +2.4% |
| Q3 2016 | $620,000 | -6.2% | 153,587 | +2.0% | 0.08% | -11.8% |
| Q2 2016 | $661,000 | +88.9% | 150,643 | +62.5% | 0.09% | +322.7% |
| Q1 2016 | $350,000 | -54.8% | 92,694 | +87.5% | 0.02% | -77.6% |
| Q4 2015 | $775,000 | – | 49,436 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |